213 related articles for article (PubMed ID: 38448646)
1. Risk factor analysis and clinicopathological characteristics of female dogs with mammary tumours from a single-center retrospective study in Poland.
Dolka I; Czopowicz M; Stopka D; Wojtkowska A; Kaszak I; Sapierzyński R
Sci Rep; 2024 Mar; 14(1):5569. PubMed ID: 38448646
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and classification for canine and feline mammary gland tumors: a histopathological survey of 437 mammary gland tumor biopsies performed in a secondary care hospital in Chiang Mai, Thailand from 2012 to 2019.
Srisawat W; Pringproa K; Prachasilchai W; Thongtharb A; Sthitmatee N
PeerJ; 2024; 12():e17077. PubMed ID: 38500523
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumour-associated macrophages in canine mammary tumours.
Raposo T; Gregório H; Pires I; Prada J; Queiroga FL
Vet Comp Oncol; 2014 Mar; 12(1):10-9. PubMed ID: 22533625
[TBL] [Abstract][Full Text] [Related]
4. Expression and prognostic value of c-met in canine mammary tumours.
Chen YC; Chen YY; Liao JW; Chang SC
Vet Comp Oncol; 2018 Dec; 16(4):670-676. PubMed ID: 30129270
[TBL] [Abstract][Full Text] [Related]
5. Canine mammary tumours: Size matters-a progression from low to highly malignant subtypes.
Gedon J; Wehrend A; Failing K; Kessler M
Vet Comp Oncol; 2021 Dec; 19(4):707-713. PubMed ID: 32945086
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis, classification and grading of canine mammary tumours as a model to study human breast cancer: an Clinico-Cytohistopathological study with environmental factors influencing public health and medicine.
Shafiee R; Javanbakht J; Atyabi N; Kheradmand P; Kheradmand D; Bahrami A; Daraei H; Khadivar F
Cancer Cell Int; 2013; 13():79. PubMed ID: 23937693
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology of canine mammary tumours on the Canary Archipelago in Spain.
Rodríguez J; Santana Á; Herráez P; Killick DR; de Los Monteros AE
BMC Vet Res; 2022 Jul; 18(1):268. PubMed ID: 35821034
[TBL] [Abstract][Full Text] [Related]
8. Canine mammary gland disease in New Zealand: a review of samples from 797 dogs.
Ariyarathna H; Aberdein D; Thomson N; Gibson I; Munday JS
N Z Vet J; 2022 Mar; 70(2):95-100. PubMed ID: 34756151
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of TRPM7 in canine mammary tumours.
Lee S; Lee S; Kim WH
Vet Comp Oncol; 2021 Sep; 19(3):510-517. PubMed ID: 33617107
[TBL] [Abstract][Full Text] [Related]
10. Significant association of serum autoantibodies to TYMS, HAPLN1 and IGFBP5 with early stage canine malignant mammary tumours.
Chang SC; Yuan SH; Li CY; Chang HM; Wang HC; Pan YA; Hsueh PC; Wu CC; Yang Y; Liu HP
Vet Comp Oncol; 2021 Mar; 19(1):172-182. PubMed ID: 33038064
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of Occult Isolated Tumour Cells within Regional Lymph Nodes of Dogs with Malignant Mammary Tumours.
Coleto AF; Wilson TM; Soares NP; Gundim LF; Castro IP; Guimarães EC; Bandarra MB; Medeiros-Ronchi AA
J Comp Pathol; 2018 Jan; 158():32-38. PubMed ID: 29422313
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Dog Breed and Clinical Features of Mammary Epithelial Neoplasia in Bitches: an Epidemiological Study of Submissions to a Single Diagnostic Pathology Centre Between 2008-2021.
Edmunds G; Beck S; Kale KU; Spasic I; O'Neill D; Brodbelt D; Smalley MJ
J Mammary Gland Biol Neoplasia; 2023 Mar; 28(1):6. PubMed ID: 36961631
[TBL] [Abstract][Full Text] [Related]
13. A retrospective study and survival analysis on bitches with mammary tumours spayed at the same time of mastectomy.
Banchi P; Morello EM; Bertero A; Ricci A; Rota A
Vet Comp Oncol; 2022 Mar; 20(1):172-178. PubMed ID: 34351034
[TBL] [Abstract][Full Text] [Related]
14. Expression frequency of c-kit isoforms and its prognostic potential in canine mammary tumours.
Chen YC; Liao JW; Chang SC; Hsu WL
Vet Comp Oncol; 2020 Sep; 18(3):303-314. PubMed ID: 31652393
[TBL] [Abstract][Full Text] [Related]
15. A statistical assessment of the biological relationship between simultaneous canine mammary tumours.
Gunnes G; Borge KS; Lingaas F
Vet Comp Oncol; 2017 Jun; 15(2):355-365. PubMed ID: 26452754
[TBL] [Abstract][Full Text] [Related]
16. The ESR1 gene is associated with risk for canine mammary tumours.
Borge KS; Melin M; Rivera P; Thoresen SI; Webster MT; von Euler H; Lindblad-Toh K; Lingaas F
BMC Vet Res; 2013 Apr; 9():69. PubMed ID: 23574728
[TBL] [Abstract][Full Text] [Related]
17. Solitary and multiple simultaneous malignant epithelial mammary tumours in dogs: An explorative retrospective study.
Pecile A; Groppetti D; Ferrari R; Grieco V; Giudice C; Spediacci C; Stefanello D; Boracchi P
Res Vet Sci; 2021 Mar; 135():153-161. PubMed ID: 33524825
[TBL] [Abstract][Full Text] [Related]
18. Oestrogen and progesterone receptor expression in subtypes of canine mammary tumours in intact and ovariectomised dogs.
Mainenti M; Rasotto R; Carnier P; Zappulli V
Vet J; 2014 Oct; 202(1):62-8. PubMed ID: 24980810
[TBL] [Abstract][Full Text] [Related]
19. Canine mammary gland tumours; a histological continuum from benign to malignant; clinical and histopathological evidence.
Sorenmo KU; Kristiansen VM; Cofone MA; Shofer FS; Breen AM; Langeland M; Mongil CM; Grondahl AM; Teige J; Goldschmidt MH
Vet Comp Oncol; 2009 Sep; 7(3):162-72. PubMed ID: 19691645
[TBL] [Abstract][Full Text] [Related]
20. Expression of the Hippo signalling effectors YAP and TAZ in canine mammary gland hyperplasia and malignant transformation of mammary tumours.
Rico C; Boerboom D; Paquet M
Vet Comp Oncol; 2018 Dec; 16(4):630-635. PubMed ID: 30117264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
